Synthpop

About Synthpop

Synthpop, Inc. is a healthcare technology company founded in 2023 that provides an AI-driven platform to automate administrative workflows. The company was established by CEO Elad Ferber and CTO Jan Jannink. Ferber previously co-founded Spry Health, a remote patient monitoring startup acquired by Itamar Medical in 2021, providing him with direct experience in bringing machine learning products to the digital health market. Jannink is a seasoned startup founder, has held CTO roles at several companies, and teaches about Large Language Models at Stanford University, bringing deep technical and architectural expertise to the firm.

The company targets the significant administrative burden in healthcare, a market with potential annual savings of up to $265 billion through simplification and standardization. Synthpop serves a variety of healthcare organizations, including durable medical equipment (DME) providers, independent diagnostic testing facilities (IDTFs), and providers in specialties like Sleep Medicine, Wound Care, and Genetic Testing. Its business model is based on positioning its AI agents as a labor solution rather than just software, charging clients on a per-task basis to automate repetitive administrative functions. This approach is designed to integrate seamlessly into existing client systems like EHRs and ERPs without requiring costly or lengthy configurations.

Synthpop's platform utilizes multimodal Large Language Models (LLMs) to handle complex administrative tasks. The product suite includes several key tools: 'Fax Wrangler' for sorting and processing incoming faxes, 'Field Extractor' for data entry, and 'Order Validation' for checking medical orders against payor and clinical guidelines. A significant offering is the 'AI caller,' a conversational voice agent that can place and receive calls to handle tasks like obtaining prior authorization and checking claim status. These AI agents are designed to work alongside human teams, taking over tedious tasks to reduce professional burnout and allow staff to focus on patient care. The platform ensures data security and HIPAA compliance by training its models on de-identified medical data and has undergone a SOC2 audit.

Since its inception, Synthpop has shown rapid traction, securing an initial $2.6 million in seed funding in August 2023, followed by a larger $5.6 million seed round in June 2024. The funding rounds were led by investors including Peterson Ventures, defy.vc, and Zelda Ventures. The capital is being used to expand the engineering team and enhance product development as the company scales its operations across different healthcare sectors.